-
Epigenetic MIR9 Silencing Drives FGFR1/CDK6 in ALL Prognosis
2026-07-08
This study establishes that epigenetic silencing of the MIR9 microRNA family via promoter hypermethylation leads to upregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia (ALL). MIR9 methylation emerges as an independent prognostic factor for survival, highlighting the therapeutic potential of targeting epigenetic regulation or the implicated pathways in ALL.
-
Reliable Signaling Pathway Modulation with (S)-1-(3-fluoro-4
2026-07-08
(S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea (SKU A8959) offers biomedical researchers a high-purity, well-validated tool for consistent signaling pathway and enzyme inhibition studies. This article addresses real-world challenges in cell viability, proliferation, and cytotoxicity assays, and demonstrates how SKU A8959 improves reproducibility and workflow efficiency through evidence-backed practices.
-
Streptavidin-FITC: Precision Fluorescent Detection in LNP As
2026-07-07
Streptavidin-FITC empowers researchers with high-sensitivity, quantitative fluorescent detection of biotinylated molecules, underpinning advanced workflows from immunohistochemistry to real-time lipid nanoparticle (LNP) trafficking studies. APExBIO's product uniquely bridges robust performance and assay reliability, enabling translational insights into endosomal dynamics and intracellular delivery.
-
Targeting the CaN/FoxO1/FABP4 Pathway to Inhibit Foam Cell F
2026-07-07
This study uncovers how SERCA2 dysfunction accelerates atherosclerosis by activating the calcineurin/FoxO1/FABP4 pathway, promoting foam cell formation in macrophages. Pharmacological inhibition of FABP4, including with selective inhibitors, corrects lipid metabolic disturbances and reduces lesion development, offering a targeted approach for atherosclerosis research.
-
Liproxstatin-1 HCl in Ferroptosis Assays: Protocols & Innova
2026-07-06
Liproxstatin-1 HCl empowers researchers with precise inhibition of lipid peroxidation in ferroptosis models, offering nanomolar sensitivity and robust workflow reproducibility. This guide translates the latest mitochondrial calcium signaling discoveries into actionable assay enhancements and troubleshooting strategies for acute renal failure and hepatic injury research.
-
Angiotensin 1/2 (1-6): Applied Workflows in RAS & Viral Rese
2026-07-06
Angiotensin 1/2 (1-6) uniquely bridges renin-angiotensin system research and emerging viral pathogenesis assays, enabling precision studies of vascular tone modulation and receptor biology. APExBIO’s high-purity Asp-Arg-Val-Tyr-Ile-His hexapeptide empowers reproducible, high-fidelity investigations in cardiovascular, renal, and cross-domain viral workflows.
-
Hexetidine (NSC-17764): Precision Antibacterial Strategies f
2026-07-05
Hexetidine (NSC-17764) stands out as a broad-spectrum antibacterial agent for oral infections and biofilm inhibition, offering distinct advantages in both in vitro and clinical contexts. Its unique mechanism and resistance to surface adsorption make it ideal for researchers seeking reliable, quantifiable antimicrobial results.
-
Enzymatic Synthesis of Fatty Amines from Trilaurin: Advances
2026-07-04
The referenced study presents a direct, biocatalytic method for synthesizing primary fatty amines from renewable triglycerides such as trilaurin. This innovation enables high-yield, selective production of valuable fatty amines under mild conditions, offering a sustainable alternative to traditional, metal-catalyzed processes and informing both chemical and pharmaceutical research.
-
Deferiprone (SKU B1723): Precision Iron Modulation for Cell
2026-07-03
This article provides scenario-driven, evidence-based guidance on using Deferiprone (3-hydroxy-1,2-dimethylpyridin-4-one, SKU B1723) for experimental control in cell viability, proliferation, and cytotoxicity assays. Drawing on recent metabolomics studies and validated workflows, it highlights how Deferiprone offers reliable, reproducible solutions to common laboratory challenges in iron-dependent signaling and apoptosis research.
-
Ceruletide in Pancreatic Function Research: Protocols & Pitf
2026-07-03
Ceruletide (caerulein) offers unmatched precision for modeling pancreatic fibrosis and gastrointestinal physiology in preclinical settings. This article demystifies advanced workflows, integrates the latest mechanistic findings, and provides actionable troubleshooting tips—empowering researchers to optimize every step of their digestive disorder studies.
-
A-769662 and the New Paradigm of AMPK: Guidance for Translat
2026-07-02
A-769662, a potent and reversible AMPK activator from APExBIO, is redefining the landscape of metabolic and autophagy research. This article provides translational researchers with mechanistic insights, protocol recommendations, and a strategic roadmap, integrating pivotal findings that challenge classical models of energy stress and autophagy regulation. We bridge recent evidence with practical guidance, contextualize competitive tool compounds, and anticipate the future of AMPK-targeted interventions.
-
Direct NRF2 Activation by Kaempferol Mitigates Inflammatory
2026-07-02
This study demonstrates that kaempferol directly activates NRF2 in osteoclasts, alleviating inflammatory bone loss via the NRF2/HO-1 pathway. The findings clarify the molecular mechanism of kaempferol and establish NRF2 as a targetable axis in osteolytic disease models.
-
SB525334 TGF-beta1 Receptor Inhibitor: Protocols in Fibrosis
2026-07-01
SB525334 unlocks precise, reproducible control of TGF-beta signaling in both cellular and in vivo models of fibrosis and wound healing. This guide translates cutting-edge findings—especially from diabetic wound repair research—into actionable protocols and troubleshooting strategies, enabling researchers to dissect and manipulate this critical pathway with confidence.
-
One-step TUNEL Cy5 Apoptosis Detection Kit: Beyond DNA Fragm
2026-07-01
Discover how the One-step TUNEL Cy5 Apoptosis Detection Kit empowers advanced apoptosis research, with unique insights into immune-metabolic regulation and assay optimization. Explore deeper mechanistic context and strategic assay decision-making.
-
Amikacin Disulfate in Antibiotic Mechanism Research Workflow
2026-06-30
Amikacin disulfate's unique ribosomal binding and protein–antibiotic interaction profile make it indispensable for dissecting mechanisms of bacterial protein synthesis suppression and resistance. Recent multimodal studies reveal new troubleshooting strategies, optimizing experimental reproducibility and mechanistic insight.
452 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page